| Literature DB >> 34874266 |
Jugal Mohapatra1, Kyuto Tashiro1, Ryan L Beckner1, Jorge Sierra1, Jessica A Kilgore1,2, Noelle S Williams1,2, Glen Liszczak1.
Abstract
Serine ADP-ribosylation (ADPr) is a DNA damage-induced post-translational modification catalyzed by the PARP1/2:HPF1 complex. As the list of PARP1/2:HPF1 substrates continues to expand, there is a need for technologies to prepare mono- and poly-ADP-ribosylated proteins for biochemical interrogation. Here, we investigate the unique peptide ADPr activities catalyzed by PARP1 in the absence and presence of HPF1. We then exploit these activities to develop a method that facilitates installation of ADP-ribose polymers onto peptides with precise control over chain length and modification site. Importantly, the enzymatically mono- and poly-ADP-ribosylated peptides are fully compatible with protein ligation technologies. This chemoenzymatic protein synthesis strategy was employed to assemble a series of full-length, ADP-ribosylated histones and show that ADPr at histone H2B serine 6 or histone H3 serine 10 converts nucleosomes into robust substrates for the chromatin remodeler ALC1. We found ALC1 preferentially remodels 'activated' substrates within heterogeneous mononucleosome populations and asymmetrically ADP-ribosylated dinucleosome substrates, and that nucleosome serine ADPr is sufficient to stimulate ALC1 activity in nuclear extracts. Our study identifies a biochemical function for nucleosome serine ADPr and describes a new, highly modular approach to explore the impact that site-specific serine mono- and poly-ADPr have on protein function.Entities:
Keywords: DNA damage response; E. coli; HPF1; PARP; biochemistry; chemical biology; chromosomes; gene expression; human; post-translational modifications; protein semi-synthesis
Mesh:
Substances:
Year: 2021 PMID: 34874266 PMCID: PMC8683085 DOI: 10.7554/eLife.71502
Source DB: PubMed Journal: Elife ISSN: 2050-084X Impact factor: 8.140